Avet Pharmaceuticals recalls
Avet Pharmaceuticals has 4 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 15 Apr 2020. The most frequent reason is potency & assay.
Total recalls4since 2020
Last 12 months0reported
Class I250% of total
Ongoing0latest 15 Apr 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 50%Class II 2 50%Class III 0 0%
Why avet pharmaceuticals is recalled
Product types
By year
All avet pharmaceuticals recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Losartan Potassium Tablets USP 50 mg, a) recalled | Avet Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS I | Tetracycline HCL Capsules, USP, 250 mg recalled by Avet PharmaceuticalsTetracycline Hydrochloride | Avet Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Losartan Potassium Tablets USP 100 mg, supplied in a) recalled | Avet Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS I | Tetracycline HCL Capsules, USP, 500 mg recalled by Avet PharmaceuticalsTetracycline Hydrochloride | Avet Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.